Characteristics | Overall | Groups | |
---|---|---|---|
Age (years) | 72.5 (n = 61) | A (≥65, n = 37) | B (≥75, n = 24) |
Gender | |||
Male | 38 (62.3 %) | 23 (62.2 %) | 14 (37.8) |
Female | 23 (37.7 %) | 14 (37.8 %) | 10 (41.7) |
Calcium >11 mg/dl | 4 (6.6 %) | 2 (5.4 %) | 2 (8.3 %) |
Creatinine >2.0 mg/dl | 12 (19.67 %) | 7 (18.9 %) | 5 (20.8 %) |
Hemoglobin <10 g//L | 48 (78.7 %) | 28 (75.7 %) | 20 (83.3 %) |
Bone lesions | 58 (95.1 %) | 35 (94.6 %) | 23 (95.8 %) |
M component at diagnosis | |||
Ig G | 29 (47.5 %) | 16 (43.2 %) | 13 (54.2 %) |
Ig A | 16 (26.2 %) | 11 (29.7 %) | 5 (20.8 %) |
Ig D | 2 (3.3 %) | 2 (5.4 %) | 0 |
Light chain | 13 (21.3 %) | 8 (21.6 %) | 5 (20.8 %) |
Non-secretory | 1 (1.6 %) | 0 | 1 (4.2 %) |
Stage of ISS | |||
I | 1 (1.6 %) | 0 | 1 (4.2 %) |
II | 20 (32.8 %) | 13 (35.1 %) | 7 (29.2 %) |
III | 40 (65.6 %) | 24 (64.9 %) | 16 (66.7 %) |
MM with EMP | 19 (31.2 %) | 12 (32.4 %) | 7 (29.2 %) |
Abnormal genetics testing | |||
G-banded karyotype testing | 4 (6.6 %) | 3 (11.5 %) | 1 (3.8 %) |
FISH | 13 (21.3 %) | 7 (26.9 %) | 5 (19.2 %) |